Code | 4976D | ||||||||||
MA number | 44/0154/20-S | ||||||||||
Product Form: | tbl flm 60x200 mg (blis.Al/OPA/Al/PVC) | ||||||||||
MA Status: | R - Valid Marketing Authorisation | ||||||||||
Type of procedure: | Decentralised | ||||||||||
MAH, country: | STADA Arzneimittel AG, Germany | ||||||||||
Therapeutic Class: | 44 - CYTOSTATICA | ||||||||||
ATC: |
|
||||||||||
Shelf life: | 48 | ||||||||||
Route of admin.: | Oral use |
Prescription Status: | Medicinal product subject to restricted medical prescription. |
Legal basis: | Article 10(1) generic application |
MA issued: | 07.07.2020 |
Validity: | 07.07.2025 |
PIL: | PIL_Sorafenib STADA_02.2023.pdf |
SPC: | SPC_Sorafenib STADA_01.2024.pdf |
Safety feature | Yes |
Data update: | 16.01.2024 |